Global Targeted Antitumor Drugs Production, Demand and Key Producers, 2022-2028
Targeted antitumor drugs use specific structural molecules of tumor tissues or cells as targets to achieve the purpose of directly killing tumor cells, and have the advantages of high specificity, high selectivity, light side reactions and high efficacy/toxicity ratio compared with chemotherapy drugs
This report studies the global Targeted Antitumor Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Targeted Antitumor Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Targeted Antitumor Drugs that contribute to its increasing demand across many markets.
The global Targeted Antitumor Drugs market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Targeted Antitumor Drugs total production and demand, 2017-2028, (K Units)
Global Targeted Antitumor Drugs total production value, 2017-2028, (USD Million)
Global Targeted Antitumor Drugs production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Targeted Antitumor Drugs consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Targeted Antitumor Drugs domestic production, consumption, key domestic manufacturers and share
Global Targeted Antitumor Drugs production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Targeted Antitumor Drugs production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Targeted Antitumor Drugs production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Targeted Antitumor Drugs market based on the following parameters – headquarters, production locations, products portfolio, Targeted Antitumor Drugs revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Targeted Antitumor Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Targeted Antitumor Drugs Market, By Region:
1. How big is the global Targeted Antitumor Drugs market?
2. What is the demand of the global Targeted Antitumor Drugs market?
3. What is the year over year growth of the global Targeted Antitumor Drugs market?
4. What is the production and production value of the global Targeted Antitumor Drugs market?
5. Who are the key producers in the global Targeted Antitumor Drugs market?
6. What are the growth factors driving the market demand?
This report studies the global Targeted Antitumor Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Targeted Antitumor Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Targeted Antitumor Drugs that contribute to its increasing demand across many markets.
The global Targeted Antitumor Drugs market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Targeted Antitumor Drugs total production and demand, 2017-2028, (K Units)
Global Targeted Antitumor Drugs total production value, 2017-2028, (USD Million)
Global Targeted Antitumor Drugs production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Targeted Antitumor Drugs consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Targeted Antitumor Drugs domestic production, consumption, key domestic manufacturers and share
Global Targeted Antitumor Drugs production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Targeted Antitumor Drugs production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Targeted Antitumor Drugs production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Targeted Antitumor Drugs market based on the following parameters – headquarters, production locations, products portfolio, Targeted Antitumor Drugs revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Targeted Antitumor Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Targeted Antitumor Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Macromolecular Targeted Antitumor Drugs
- Small Molecule Targeted Antitumor Drugs
- Lung Cancer
- Lymphoma
- Breast Cancer
- Leukaemia
- Prostate Cancer
- Multiple Bone Marrow Cancer
- Others
- Roche
- Celgene
- Novartis
- Johnson & Johnson
- Lilly
- AstraZeneca plc.
- Betta Pharmaceuticals
1. How big is the global Targeted Antitumor Drugs market?
2. What is the demand of the global Targeted Antitumor Drugs market?
3. What is the year over year growth of the global Targeted Antitumor Drugs market?
4. What is the production and production value of the global Targeted Antitumor Drugs market?
5. Who are the key producers in the global Targeted Antitumor Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Targeted Antitumor Drugs Introduction
1.2 World Targeted Antitumor Drugs Supply & Forecast
1.2.1 World Targeted Antitumor Drugs Production Value (2017 & 2021 & 2028)
1.2.2 World Targeted Antitumor Drugs Production (2017-2028)
1.2.3 World Targeted Antitumor Drugs Pricing Trends (2017-2028)
1.3 World Targeted Antitumor Drugs Production by Region
1.3.1 World Targeted Antitumor Drugs Production Value by Region (2017-2028)
1.3.2 World Targeted Antitumor Drugs Production by Region (2017-2028)
1.3.3 World Targeted Antitumor Drugs Average Price by Region (2017-2028)
1.3.4 North America Targeted Antitumor Drugs Production (2017-2028)
1.3.5 Europe Targeted Antitumor Drugs Production (2017-2028)
1.3.6 China Targeted Antitumor Drugs Production (2017-2028)
1.3.7 Japan Targeted Antitumor Drugs Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Targeted Antitumor Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Targeted Antitumor Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Targeted Antitumor Drugs Demand (2017-2028)
2.2 World Targeted Antitumor Drugs Consumption by Region
2.2.1 World Targeted Antitumor Drugs Consumption by Region (2017-2022)
2.2.2 World Targeted Antitumor Drugs Consumption Forecast by Region (2023-2028)
2.3 United States Targeted Antitumor Drugs Consumption (2017-2028)
2.4 China Targeted Antitumor Drugs Consumption (2017-2028)
2.5 Europe Targeted Antitumor Drugs Consumption (2017-2028)
2.6 Japan Targeted Antitumor Drugs Consumption (2017-2028)
2.7 South Korea Targeted Antitumor Drugs Consumption (2017-2028)
2.8 ASEAN Targeted Antitumor Drugs Consumption (2017-2028)
2.9 India Targeted Antitumor Drugs Consumption (2017-2028)
3 WORLD TARGETED ANTITUMOR DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Targeted Antitumor Drugs Production Value by Manufacturer (2017-2022)
3.2 World Targeted Antitumor Drugs Production by Manufacturer (2017-2022)
3.3 World Targeted Antitumor Drugs Average Price by Manufacturer (2017-2022)
3.4 Targeted Antitumor Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Targeted Antitumor Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Targeted Antitumor Drugs in 2021
3.5.3 Global Concentration Ratios (CR8) for Targeted Antitumor Drugs in 2021
3.6 Targeted Antitumor Drugs Market: Overall Company Footprint Analysis
3.6.1 Targeted Antitumor Drugs Market: Region Footprint
3.6.2 Targeted Antitumor Drugs Market: Company Product Type Footprint
3.6.3 Targeted Antitumor Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Targeted Antitumor Drugs Production Value Comparison
4.1.1 United States VS China: Targeted Antitumor Drugs Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Targeted Antitumor Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Targeted Antitumor Drugs Production Comparison
4.2.1 United States VS China: Targeted Antitumor Drugs Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Targeted Antitumor Drugs Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Targeted Antitumor Drugs Consumption Comparison
4.3.1 United States VS China: Targeted Antitumor Drugs Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Targeted Antitumor Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Targeted Antitumor Drugs Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Targeted Antitumor Drugs in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Targeted Antitumor Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Targeted Antitumor Drugs Production by Domestic Manufacturer, (2017-2022)
4.5 China Targeted Antitumor Drugs Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Targeted Antitumor Drugs in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Targeted Antitumor Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Targeted Antitumor Drugs Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Targeted Antitumor Drugs Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Targeted Antitumor Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Targeted Antitumor Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Targeted Antitumor Drugs Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Targeted Antitumor Drugs Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Macromolecular Targeted Antitumor Drugs
5.2.2 Small Molecule Targeted Antitumor Drugs
5.3 Market Segment by Type
5.3.1 World Targeted Antitumor Drugs Production by Type (2017-2028)
5.3.2 World Targeted Antitumor Drugs Production Value by Type (2017-2028)
5.3.3 World Targeted Antitumor Drugs Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Targeted Antitumor Drugs Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Lung Cancer
6.2.2 Lymphoma
6.2.3 Breast Cancer
6.2.4 Leukaemia
6.2.5 Prostate Cancer
6.2.6 Multiple Bone Marrow Cancer
6.2.7 Others
6.3 Market Segment by Application
6.3.1 World Targeted Antitumor Drugs Production by Application (2017-2028)
6.3.2 World Targeted Antitumor Drugs Production Value by Application (2017-2028)
6.3.3 World Targeted Antitumor Drugs Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Targeted Antitumor Drugs Product and Services
7.1.4 Roche Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Celgene
7.2.1 Celgene Details
7.2.2 Celgene Major Business
7.2.3 Celgene Targeted Antitumor Drugs Product and Services
7.2.4 Celgene Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Celgene Recent Developments/Updates
7.2.6 Celgene Competitive Strengths & Weaknesses
7.3 Novartis
7.3.1 Novartis Details
7.3.2 Novartis Major Business
7.3.3 Novartis Targeted Antitumor Drugs Product and Services
7.3.4 Novartis Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Novartis Recent Developments/Updates
7.3.6 Novartis Competitive Strengths & Weaknesses
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Details
7.4.2 Johnson & Johnson Major Business
7.4.3 Johnson & Johnson Targeted Antitumor Drugs Product and Services
7.4.4 Johnson & Johnson Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Johnson & Johnson Recent Developments/Updates
7.4.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.5 Lilly
7.5.1 Lilly Details
7.5.2 Lilly Major Business
7.5.3 Lilly Targeted Antitumor Drugs Product and Services
7.5.4 Lilly Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Lilly Recent Developments/Updates
7.5.6 Lilly Competitive Strengths & Weaknesses
7.6 AstraZeneca plc.
7.6.1 AstraZeneca plc. Details
7.6.2 AstraZeneca plc. Major Business
7.6.3 AstraZeneca plc. Targeted Antitumor Drugs Product and Services
7.6.4 AstraZeneca plc. Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 AstraZeneca plc. Recent Developments/Updates
7.6.6 AstraZeneca plc. Competitive Strengths & Weaknesses
7.7 Betta Pharmaceuticals
7.7.1 Betta Pharmaceuticals Details
7.7.2 Betta Pharmaceuticals Major Business
7.7.3 Betta Pharmaceuticals Targeted Antitumor Drugs Product and Services
7.7.4 Betta Pharmaceuticals Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Betta Pharmaceuticals Recent Developments/Updates
7.7.6 Betta Pharmaceuticals Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Targeted Antitumor Drugs and Key Manufacturers
8.2 Targeted Antitumor Drugs Manufacturing Costs
8.3 Targeted Antitumor Drugs Production Process
8.4 Targeted Antitumor Drugs Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Targeted Antitumor Drugs Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Targeted Antitumor Drugs Typical Distributors
9.3 Targeted Antitumor Drugs Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Targeted Antitumor Drugs Introduction
1.2 World Targeted Antitumor Drugs Supply & Forecast
1.2.1 World Targeted Antitumor Drugs Production Value (2017 & 2021 & 2028)
1.2.2 World Targeted Antitumor Drugs Production (2017-2028)
1.2.3 World Targeted Antitumor Drugs Pricing Trends (2017-2028)
1.3 World Targeted Antitumor Drugs Production by Region
1.3.1 World Targeted Antitumor Drugs Production Value by Region (2017-2028)
1.3.2 World Targeted Antitumor Drugs Production by Region (2017-2028)
1.3.3 World Targeted Antitumor Drugs Average Price by Region (2017-2028)
1.3.4 North America Targeted Antitumor Drugs Production (2017-2028)
1.3.5 Europe Targeted Antitumor Drugs Production (2017-2028)
1.3.6 China Targeted Antitumor Drugs Production (2017-2028)
1.3.7 Japan Targeted Antitumor Drugs Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Targeted Antitumor Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Targeted Antitumor Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Targeted Antitumor Drugs Demand (2017-2028)
2.2 World Targeted Antitumor Drugs Consumption by Region
2.2.1 World Targeted Antitumor Drugs Consumption by Region (2017-2022)
2.2.2 World Targeted Antitumor Drugs Consumption Forecast by Region (2023-2028)
2.3 United States Targeted Antitumor Drugs Consumption (2017-2028)
2.4 China Targeted Antitumor Drugs Consumption (2017-2028)
2.5 Europe Targeted Antitumor Drugs Consumption (2017-2028)
2.6 Japan Targeted Antitumor Drugs Consumption (2017-2028)
2.7 South Korea Targeted Antitumor Drugs Consumption (2017-2028)
2.8 ASEAN Targeted Antitumor Drugs Consumption (2017-2028)
2.9 India Targeted Antitumor Drugs Consumption (2017-2028)
3 WORLD TARGETED ANTITUMOR DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Targeted Antitumor Drugs Production Value by Manufacturer (2017-2022)
3.2 World Targeted Antitumor Drugs Production by Manufacturer (2017-2022)
3.3 World Targeted Antitumor Drugs Average Price by Manufacturer (2017-2022)
3.4 Targeted Antitumor Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Targeted Antitumor Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Targeted Antitumor Drugs in 2021
3.5.3 Global Concentration Ratios (CR8) for Targeted Antitumor Drugs in 2021
3.6 Targeted Antitumor Drugs Market: Overall Company Footprint Analysis
3.6.1 Targeted Antitumor Drugs Market: Region Footprint
3.6.2 Targeted Antitumor Drugs Market: Company Product Type Footprint
3.6.3 Targeted Antitumor Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Targeted Antitumor Drugs Production Value Comparison
4.1.1 United States VS China: Targeted Antitumor Drugs Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Targeted Antitumor Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Targeted Antitumor Drugs Production Comparison
4.2.1 United States VS China: Targeted Antitumor Drugs Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Targeted Antitumor Drugs Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Targeted Antitumor Drugs Consumption Comparison
4.3.1 United States VS China: Targeted Antitumor Drugs Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Targeted Antitumor Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Targeted Antitumor Drugs Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Targeted Antitumor Drugs in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Targeted Antitumor Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Targeted Antitumor Drugs Production by Domestic Manufacturer, (2017-2022)
4.5 China Targeted Antitumor Drugs Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Targeted Antitumor Drugs in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Targeted Antitumor Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Targeted Antitumor Drugs Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Targeted Antitumor Drugs Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Targeted Antitumor Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Targeted Antitumor Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Targeted Antitumor Drugs Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Targeted Antitumor Drugs Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Macromolecular Targeted Antitumor Drugs
5.2.2 Small Molecule Targeted Antitumor Drugs
5.3 Market Segment by Type
5.3.1 World Targeted Antitumor Drugs Production by Type (2017-2028)
5.3.2 World Targeted Antitumor Drugs Production Value by Type (2017-2028)
5.3.3 World Targeted Antitumor Drugs Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Targeted Antitumor Drugs Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Lung Cancer
6.2.2 Lymphoma
6.2.3 Breast Cancer
6.2.4 Leukaemia
6.2.5 Prostate Cancer
6.2.6 Multiple Bone Marrow Cancer
6.2.7 Others
6.3 Market Segment by Application
6.3.1 World Targeted Antitumor Drugs Production by Application (2017-2028)
6.3.2 World Targeted Antitumor Drugs Production Value by Application (2017-2028)
6.3.3 World Targeted Antitumor Drugs Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Targeted Antitumor Drugs Product and Services
7.1.4 Roche Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Celgene
7.2.1 Celgene Details
7.2.2 Celgene Major Business
7.2.3 Celgene Targeted Antitumor Drugs Product and Services
7.2.4 Celgene Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Celgene Recent Developments/Updates
7.2.6 Celgene Competitive Strengths & Weaknesses
7.3 Novartis
7.3.1 Novartis Details
7.3.2 Novartis Major Business
7.3.3 Novartis Targeted Antitumor Drugs Product and Services
7.3.4 Novartis Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Novartis Recent Developments/Updates
7.3.6 Novartis Competitive Strengths & Weaknesses
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Details
7.4.2 Johnson & Johnson Major Business
7.4.3 Johnson & Johnson Targeted Antitumor Drugs Product and Services
7.4.4 Johnson & Johnson Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Johnson & Johnson Recent Developments/Updates
7.4.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.5 Lilly
7.5.1 Lilly Details
7.5.2 Lilly Major Business
7.5.3 Lilly Targeted Antitumor Drugs Product and Services
7.5.4 Lilly Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Lilly Recent Developments/Updates
7.5.6 Lilly Competitive Strengths & Weaknesses
7.6 AstraZeneca plc.
7.6.1 AstraZeneca plc. Details
7.6.2 AstraZeneca plc. Major Business
7.6.3 AstraZeneca plc. Targeted Antitumor Drugs Product and Services
7.6.4 AstraZeneca plc. Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 AstraZeneca plc. Recent Developments/Updates
7.6.6 AstraZeneca plc. Competitive Strengths & Weaknesses
7.7 Betta Pharmaceuticals
7.7.1 Betta Pharmaceuticals Details
7.7.2 Betta Pharmaceuticals Major Business
7.7.3 Betta Pharmaceuticals Targeted Antitumor Drugs Product and Services
7.7.4 Betta Pharmaceuticals Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Betta Pharmaceuticals Recent Developments/Updates
7.7.6 Betta Pharmaceuticals Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Targeted Antitumor Drugs and Key Manufacturers
8.2 Targeted Antitumor Drugs Manufacturing Costs
8.3 Targeted Antitumor Drugs Production Process
8.4 Targeted Antitumor Drugs Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Targeted Antitumor Drugs Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Targeted Antitumor Drugs Typical Distributors
9.3 Targeted Antitumor Drugs Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Targeted Antitumor Drugs Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Targeted Antitumor Drugs Production Value by Region (2017-2022) & (USD Million)
Table 3. World Targeted Antitumor Drugs Production Value by Region (2023-2028) & (USD Million)
Table 4. World Targeted Antitumor Drugs Production Value Market Share by Region (2017-2022)
Table 5. World Targeted Antitumor Drugs Production Value Market Share by Region (2023-2028)
Table 6. World Targeted Antitumor Drugs Production by Region (2017-2022) & (K Units)
Table 7. World Targeted Antitumor Drugs Production by Region (2023-2028) & (K Units)
Table 8. World Targeted Antitumor Drugs Production Market Share by Region (2017-2022)
Table 9. World Targeted Antitumor Drugs Production Market Share by Region (2023-2028)
Table 10. World Targeted Antitumor Drugs Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Targeted Antitumor Drugs Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Targeted Antitumor Drugs Major Market Trends
Table 13. World Targeted Antitumor Drugs Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Targeted Antitumor Drugs Consumption by Region (2017-2022) & (K Units)
Table 15. World Targeted Antitumor Drugs Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Targeted Antitumor Drugs Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Targeted Antitumor Drugs Producers in 2021
Table 18. World Targeted Antitumor Drugs Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Targeted Antitumor Drugs Producers in 2021
Table 20. World Targeted Antitumor Drugs Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Targeted Antitumor Drugs Company Evaluation Quadrant
Table 22. World Targeted Antitumor Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Targeted Antitumor Drugs Production Site of Key Manufacturer
Table 24. Targeted Antitumor Drugs Market: Company Product Type Footprint
Table 25. Targeted Antitumor Drugs Market: Company Product Application Footprint
Table 26. Targeted Antitumor Drugs Competitive Factors
Table 27. Targeted Antitumor Drugs New Entrant and Capacity Expansion Plans
Table 28. Targeted Antitumor Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Targeted Antitumor Drugs Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Targeted Antitumor Drugs Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Targeted Antitumor Drugs Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Targeted Antitumor Drugs in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Targeted Antitumor Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Targeted Antitumor Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Targeted Antitumor Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Targeted Antitumor Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Targeted Antitumor Drugs in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Targeted Antitumor Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Targeted Antitumor Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Targeted Antitumor Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Targeted Antitumor Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Targeted Antitumor Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Targeted Antitumor Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Targeted Antitumor Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Targeted Antitumor Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Targeted Antitumor Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Targeted Antitumor Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Targeted Antitumor Drugs Production by Type (2017-2022) & (K Units)
Table 49. World Targeted Antitumor Drugs Production by Type (2023-2028) & (K Units)
Table 50. World Targeted Antitumor Drugs Production Value by Type (2017-2022) & (USD Million)
Table 51. World Targeted Antitumor Drugs Production Value by Type (2023-2028) & (USD Million)
Table 52. World Targeted Antitumor Drugs Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Targeted Antitumor Drugs Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Targeted Antitumor Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Targeted Antitumor Drugs Production by Application (2017-2022) & (K Units)
Table 56. World Targeted Antitumor Drugs Production by Application (2023-2028) & (K Units)
Table 57. World Targeted Antitumor Drugs Production Value by Application (2017-2022) & (USD Million)
Table 58. World Targeted Antitumor Drugs Production Value by Application (2023-2028) & (USD Million)
Table 59. World Targeted Antitumor Drugs Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Targeted Antitumor Drugs Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Roche Basic Information, Manufacturing Base and Competitors
Table 62. Roche Major Business
Table 63. Roche Targeted Antitumor Drugs Product and Services
Table 64. Roche Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Roche Recent Developments/Updates
Table 66. Roche Competitive Strengths & Weaknesses
Table 67. Celgene Basic Information, Manufacturing Base and Competitors
Table 68. Celgene Major Business
Table 69. Celgene Targeted Antitumor Drugs Product and Services
Table 70. Celgene Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Celgene Recent Developments/Updates
Table 72. Celgene Competitive Strengths & Weaknesses
Table 73. Novartis Basic Information, Manufacturing Base and Competitors
Table 74. Novartis Major Business
Table 75. Novartis Targeted Antitumor Drugs Product and Services
Table 76. Novartis Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Novartis Recent Developments/Updates
Table 78. Novartis Competitive Strengths & Weaknesses
Table 79. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 80. Johnson & Johnson Major Business
Table 81. Johnson & Johnson Targeted Antitumor Drugs Product and Services
Table 82. Johnson & Johnson Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Johnson & Johnson Recent Developments/Updates
Table 84. Johnson & Johnson Competitive Strengths & Weaknesses
Table 85. Lilly Basic Information, Manufacturing Base and Competitors
Table 86. Lilly Major Business
Table 87. Lilly Targeted Antitumor Drugs Product and Services
Table 88. Lilly Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Lilly Recent Developments/Updates
Table 90. Lilly Competitive Strengths & Weaknesses
Table 91. AstraZeneca plc. Basic Information, Manufacturing Base and Competitors
Table 92. AstraZeneca plc. Major Business
Table 93. AstraZeneca plc. Targeted Antitumor Drugs Product and Services
Table 94. AstraZeneca plc. Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. AstraZeneca plc. Recent Developments/Updates
Table 96. Betta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 97. Betta Pharmaceuticals Major Business
Table 98. Betta Pharmaceuticals Targeted Antitumor Drugs Product and Services
Table 99. Betta Pharmaceuticals Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 100. Targeted Antitumor Drugs Raw Material
Table 101. Key Manufacturers of Targeted Antitumor Drugs Raw Materials
Table 102. Targeted Antitumor Drugs Typical Distributors
Table 103. Targeted Antitumor Drugs Typical Customers
Table 1. World Targeted Antitumor Drugs Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Targeted Antitumor Drugs Production Value by Region (2017-2022) & (USD Million)
Table 3. World Targeted Antitumor Drugs Production Value by Region (2023-2028) & (USD Million)
Table 4. World Targeted Antitumor Drugs Production Value Market Share by Region (2017-2022)
Table 5. World Targeted Antitumor Drugs Production Value Market Share by Region (2023-2028)
Table 6. World Targeted Antitumor Drugs Production by Region (2017-2022) & (K Units)
Table 7. World Targeted Antitumor Drugs Production by Region (2023-2028) & (K Units)
Table 8. World Targeted Antitumor Drugs Production Market Share by Region (2017-2022)
Table 9. World Targeted Antitumor Drugs Production Market Share by Region (2023-2028)
Table 10. World Targeted Antitumor Drugs Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Targeted Antitumor Drugs Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Targeted Antitumor Drugs Major Market Trends
Table 13. World Targeted Antitumor Drugs Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Targeted Antitumor Drugs Consumption by Region (2017-2022) & (K Units)
Table 15. World Targeted Antitumor Drugs Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Targeted Antitumor Drugs Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Targeted Antitumor Drugs Producers in 2021
Table 18. World Targeted Antitumor Drugs Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Targeted Antitumor Drugs Producers in 2021
Table 20. World Targeted Antitumor Drugs Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Targeted Antitumor Drugs Company Evaluation Quadrant
Table 22. World Targeted Antitumor Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Targeted Antitumor Drugs Production Site of Key Manufacturer
Table 24. Targeted Antitumor Drugs Market: Company Product Type Footprint
Table 25. Targeted Antitumor Drugs Market: Company Product Application Footprint
Table 26. Targeted Antitumor Drugs Competitive Factors
Table 27. Targeted Antitumor Drugs New Entrant and Capacity Expansion Plans
Table 28. Targeted Antitumor Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Targeted Antitumor Drugs Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Targeted Antitumor Drugs Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Targeted Antitumor Drugs Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Targeted Antitumor Drugs in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Targeted Antitumor Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Targeted Antitumor Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Targeted Antitumor Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Targeted Antitumor Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Targeted Antitumor Drugs in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Targeted Antitumor Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Targeted Antitumor Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Targeted Antitumor Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Targeted Antitumor Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Targeted Antitumor Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Targeted Antitumor Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Targeted Antitumor Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Targeted Antitumor Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Targeted Antitumor Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Targeted Antitumor Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Targeted Antitumor Drugs Production by Type (2017-2022) & (K Units)
Table 49. World Targeted Antitumor Drugs Production by Type (2023-2028) & (K Units)
Table 50. World Targeted Antitumor Drugs Production Value by Type (2017-2022) & (USD Million)
Table 51. World Targeted Antitumor Drugs Production Value by Type (2023-2028) & (USD Million)
Table 52. World Targeted Antitumor Drugs Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Targeted Antitumor Drugs Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Targeted Antitumor Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Targeted Antitumor Drugs Production by Application (2017-2022) & (K Units)
Table 56. World Targeted Antitumor Drugs Production by Application (2023-2028) & (K Units)
Table 57. World Targeted Antitumor Drugs Production Value by Application (2017-2022) & (USD Million)
Table 58. World Targeted Antitumor Drugs Production Value by Application (2023-2028) & (USD Million)
Table 59. World Targeted Antitumor Drugs Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Targeted Antitumor Drugs Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Roche Basic Information, Manufacturing Base and Competitors
Table 62. Roche Major Business
Table 63. Roche Targeted Antitumor Drugs Product and Services
Table 64. Roche Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Roche Recent Developments/Updates
Table 66. Roche Competitive Strengths & Weaknesses
Table 67. Celgene Basic Information, Manufacturing Base and Competitors
Table 68. Celgene Major Business
Table 69. Celgene Targeted Antitumor Drugs Product and Services
Table 70. Celgene Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Celgene Recent Developments/Updates
Table 72. Celgene Competitive Strengths & Weaknesses
Table 73. Novartis Basic Information, Manufacturing Base and Competitors
Table 74. Novartis Major Business
Table 75. Novartis Targeted Antitumor Drugs Product and Services
Table 76. Novartis Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Novartis Recent Developments/Updates
Table 78. Novartis Competitive Strengths & Weaknesses
Table 79. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 80. Johnson & Johnson Major Business
Table 81. Johnson & Johnson Targeted Antitumor Drugs Product and Services
Table 82. Johnson & Johnson Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Johnson & Johnson Recent Developments/Updates
Table 84. Johnson & Johnson Competitive Strengths & Weaknesses
Table 85. Lilly Basic Information, Manufacturing Base and Competitors
Table 86. Lilly Major Business
Table 87. Lilly Targeted Antitumor Drugs Product and Services
Table 88. Lilly Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Lilly Recent Developments/Updates
Table 90. Lilly Competitive Strengths & Weaknesses
Table 91. AstraZeneca plc. Basic Information, Manufacturing Base and Competitors
Table 92. AstraZeneca plc. Major Business
Table 93. AstraZeneca plc. Targeted Antitumor Drugs Product and Services
Table 94. AstraZeneca plc. Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. AstraZeneca plc. Recent Developments/Updates
Table 96. Betta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 97. Betta Pharmaceuticals Major Business
Table 98. Betta Pharmaceuticals Targeted Antitumor Drugs Product and Services
Table 99. Betta Pharmaceuticals Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 100. Targeted Antitumor Drugs Raw Material
Table 101. Key Manufacturers of Targeted Antitumor Drugs Raw Materials
Table 102. Targeted Antitumor Drugs Typical Distributors
Table 103. Targeted Antitumor Drugs Typical Customers
LIST OF FIGURES
Figure 1. Targeted Antitumor Drugs Picture
Figure 2. World Targeted Antitumor Drugs Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Targeted Antitumor Drugs Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Targeted Antitumor Drugs Production (2017-2028) & (K Units)
Figure 5. World Targeted Antitumor Drugs Average Price (2017-2028) & (US$/Unit)
Figure 6. World Targeted Antitumor Drugs Production Value Market Share by Region (2017-2028)
Figure 7. World Targeted Antitumor Drugs Production Market Share by Region (2017-2028)
Figure 8. North America Targeted Antitumor Drugs Production (2017-2028) & (K Units)
Figure 9. Europe Targeted Antitumor Drugs Production (2017-2028) & (K Units)
Figure 10. China Targeted Antitumor Drugs Production (2017-2028) & (K Units)
Figure 11. Japan Targeted Antitumor Drugs Production (2017-2028) & (K Units)
Figure 12. Targeted Antitumor Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Targeted Antitumor Drugs Demand (2017-2028) & (K Units)
Figure 15. World Targeted Antitumor Drugs Consumption Market Share by Region (2017-2028)
Figure 16. United States Targeted Antitumor Drugs Consumption (2017-2028) & (K Units)
Figure 17. China Targeted Antitumor Drugs Consumption (2017-2028) & (K Units)
Figure 18. Europe Targeted Antitumor Drugs Consumption (2017-2028) & (K Units)
Figure 19. Japan Targeted Antitumor Drugs Consumption (2017-2028) & (K Units)
Figure 20. South Korea Targeted Antitumor Drugs Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Targeted Antitumor Drugs Consumption (2017-2028) & (K Units)
Figure 22. India Targeted Antitumor Drugs Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Targeted Antitumor Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Targeted Antitumor Drugs Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Targeted Antitumor Drugs Markets in 2021
Figure 26. United States VS China: Targeted Antitumor Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Targeted Antitumor Drugs Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Targeted Antitumor Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Targeted Antitumor Drugs in United States
Figure 30. Key Producers and Market Share of Targeted Antitumor Drugs in China
Figure 31. Key Producers and Market Share of Targeted Antitumor Drugs in Rest of World
Figure 32. World Targeted Antitumor Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Targeted Antitumor Drugs Production Value Market Share by Type in 2021
Figure 34. Macromolecular Targeted Antitumor Drugs
Figure 35. Small Molecule Targeted Antitumor Drugs
Figure 36. World Targeted Antitumor Drugs Production Market Share by Type (2017-2028)
Figure 37. World Targeted Antitumor Drugs Production Value Market Share by Type (2017-2028)
Figure 38. World Targeted Antitumor Drugs Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Targeted Antitumor Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Targeted Antitumor Drugs Production Value Market Share by Application in 2021
Figure 41. Lung Cancer
Figure 42. Lymphoma
Figure 43. Breast Cancer
Figure 44. Leukaemia
Figure 45. Prostate Cancer
Figure 46. Multiple Bone Marrow Cancer
Figure 47. Others
Figure 48. World Targeted Antitumor Drugs Production Market Share by Application (2017-2028)
Figure 49. World Targeted Antitumor Drugs Production Value Market Share by Application (2017-2028)
Figure 50. World Targeted Antitumor Drugs Average Price by Application (2017-2028) & (US$/Unit)
Figure 51. Manufacturing Cost Structure Analysis of Targeted Antitumor Drugs in 2021
Figure 52. Manufacturing Process Analysis of Targeted Antitumor Drugs
Figure 53. Targeted Antitumor Drugs Industrial Chain
Figure 54. Distribution Channel Breakdown for Targeted Antitumor Drugs Shipments (%): 2017-2028
Figure 55. Direct Channel Pros & Cons
Figure 56. Indirect Channel Pros & Cons
Figure 57. Methodology
Figure 58. Research Process and Data Source
Figure 1. Targeted Antitumor Drugs Picture
Figure 2. World Targeted Antitumor Drugs Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Targeted Antitumor Drugs Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Targeted Antitumor Drugs Production (2017-2028) & (K Units)
Figure 5. World Targeted Antitumor Drugs Average Price (2017-2028) & (US$/Unit)
Figure 6. World Targeted Antitumor Drugs Production Value Market Share by Region (2017-2028)
Figure 7. World Targeted Antitumor Drugs Production Market Share by Region (2017-2028)
Figure 8. North America Targeted Antitumor Drugs Production (2017-2028) & (K Units)
Figure 9. Europe Targeted Antitumor Drugs Production (2017-2028) & (K Units)
Figure 10. China Targeted Antitumor Drugs Production (2017-2028) & (K Units)
Figure 11. Japan Targeted Antitumor Drugs Production (2017-2028) & (K Units)
Figure 12. Targeted Antitumor Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Targeted Antitumor Drugs Demand (2017-2028) & (K Units)
Figure 15. World Targeted Antitumor Drugs Consumption Market Share by Region (2017-2028)
Figure 16. United States Targeted Antitumor Drugs Consumption (2017-2028) & (K Units)
Figure 17. China Targeted Antitumor Drugs Consumption (2017-2028) & (K Units)
Figure 18. Europe Targeted Antitumor Drugs Consumption (2017-2028) & (K Units)
Figure 19. Japan Targeted Antitumor Drugs Consumption (2017-2028) & (K Units)
Figure 20. South Korea Targeted Antitumor Drugs Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Targeted Antitumor Drugs Consumption (2017-2028) & (K Units)
Figure 22. India Targeted Antitumor Drugs Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Targeted Antitumor Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Targeted Antitumor Drugs Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Targeted Antitumor Drugs Markets in 2021
Figure 26. United States VS China: Targeted Antitumor Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Targeted Antitumor Drugs Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Targeted Antitumor Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Targeted Antitumor Drugs in United States
Figure 30. Key Producers and Market Share of Targeted Antitumor Drugs in China
Figure 31. Key Producers and Market Share of Targeted Antitumor Drugs in Rest of World
Figure 32. World Targeted Antitumor Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Targeted Antitumor Drugs Production Value Market Share by Type in 2021
Figure 34. Macromolecular Targeted Antitumor Drugs
Figure 35. Small Molecule Targeted Antitumor Drugs
Figure 36. World Targeted Antitumor Drugs Production Market Share by Type (2017-2028)
Figure 37. World Targeted Antitumor Drugs Production Value Market Share by Type (2017-2028)
Figure 38. World Targeted Antitumor Drugs Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Targeted Antitumor Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Targeted Antitumor Drugs Production Value Market Share by Application in 2021
Figure 41. Lung Cancer
Figure 42. Lymphoma
Figure 43. Breast Cancer
Figure 44. Leukaemia
Figure 45. Prostate Cancer
Figure 46. Multiple Bone Marrow Cancer
Figure 47. Others
Figure 48. World Targeted Antitumor Drugs Production Market Share by Application (2017-2028)
Figure 49. World Targeted Antitumor Drugs Production Value Market Share by Application (2017-2028)
Figure 50. World Targeted Antitumor Drugs Average Price by Application (2017-2028) & (US$/Unit)
Figure 51. Manufacturing Cost Structure Analysis of Targeted Antitumor Drugs in 2021
Figure 52. Manufacturing Process Analysis of Targeted Antitumor Drugs
Figure 53. Targeted Antitumor Drugs Industrial Chain
Figure 54. Distribution Channel Breakdown for Targeted Antitumor Drugs Shipments (%): 2017-2028
Figure 55. Direct Channel Pros & Cons
Figure 56. Indirect Channel Pros & Cons
Figure 57. Methodology
Figure 58. Research Process and Data Source
